Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2012 Jun;29(2):1314-27.
doi: 10.1007/s12032-011-9846-7. Epub 2011 Feb 8.

Metformin and cancer: new applications for an old drug

Taxiarchis V Kourelis  1 , Robert D Siegel
Affiliations
Review

Metformin and cancer: new applications for an old drug

Taxiarchis V Kourelis et al. Med Oncol. 2012 Jun.

Abstract

Metformin, one of most widely prescribed oral hypoglycemic agents, has recently received increased attention because of its potential antitumorigenic effects that are thought to be independent of its hypoglycemic effects. Several potential mechanisms have been suggested for the ability of metformin to suppress cancer growth in vitro and vivo: (1) activation of LKB1/AMPK pathway, (2) induction of cell cycle arrest and/or apoptosis, (3) inhibition of protein synthesis, (4) reduction in circulating insulin levels, (5) inhibition of the unfolded protein response (UPR), (6) activation of the immune system, and (7) eradication of cancer stem cells. There is also a growing number of evidence, mostly in the form of retrospective clinical studies that suggest that metformin may be associated with a decreased risk of developing cancer and with a better response to chemotherapy. There are currently several ongoing randomized clinical trials that incorporate metformin as an adjuvant to classic chemotherapy and aim to evaluate its potential benefits in this setting. This review highlights basic aspects of the molecular biology of metformin and summarizes new advances in basic science as well as intriguing results from recent clinical studies.

PubMed Disclaimer

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. Cell Cycle. 2010 Sep 15;9(18):3807-14 - PubMed
    1. J Clin Oncol. 2009 Dec 1;27(34):e226; author reply e227 - PubMed
    1. Mol Cell. 2008 Apr 25;30(2):214-26 - PubMed
    1. JAMA. 1995 May 24-31;273(20):1605-9 - PubMed
    1. Breast Cancer Res Treat. 2011 Apr;126(2):355-64 - PubMed

MeSH terms